- Home
- ACTU vs SENS Comparison
ACTU vs SENS Comparison
Compare ACTU & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- SENS
- Stock Information
- Founded
- ACTU 2015
- SENS 1996
- Country
- ACTU United States
- SENS United States
- Employees
- ACTU N/A
- SENS N/A
- Industry
- ACTU
- SENS Industrial Machinery/Components
- Sector
- ACTU
- SENS Industrials
- Exchange
- ACTU NYSE
- SENS Nasdaq
- Market Cap
- ACTU 153.1M
- SENS 179.7M
- IPO Year
- ACTU 2024
- SENS N/A
- Fundamental
- Price
- ACTU $7.53
- SENS $0.48
- Analyst Decision
- ACTU
- SENS Strong Buy
- Analyst Count
- ACTU 0
- SENS 1
- Target Price
- ACTU N/A
- SENS $2.00
- AVG Volume (30 Days)
- ACTU 74.0K
- SENS 12.5M
- Earning Date
- ACTU 11-13-2024
- SENS 11-07-2024
- Dividend Yield
- ACTU N/A
- SENS N/A
- EPS Growth
- ACTU N/A
- SENS N/A
- EPS
- ACTU N/A
- SENS N/A
- Revenue
- ACTU N/A
- SENS $22,205,000.00
- Revenue This Year
- ACTU N/A
- SENS $1.05
- Revenue Next Year
- ACTU N/A
- SENS $61.23
- P/E Ratio
- ACTU N/A
- SENS N/A
- Revenue Growth
- ACTU N/A
- SENS 11.41
- 52 Week Low
- ACTU $5.51
- SENS $0.25
- 52 Week High
- ACTU $10.16
- SENS $0.75
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- SENS 71.54
- Support Level
- ACTU N/A
- SENS $0.40
- Resistance Level
- ACTU N/A
- SENS $0.50
- Average True Range (ATR)
- ACTU 0.00
- SENS 0.05
- MACD
- ACTU 0.00
- SENS 0.01
- Stochastic Oscillator
- ACTU 0.00
- SENS 81.22
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.